| Clofarabine |
ЕU/1/06/334/005 |
EVOLTRA, Concentrate for solution for infusion, 1 mg/ml - 20 ml, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Penn Pharmaceutical Services Limited; Великобритания; Pharmachemie B.V (PCH) - Холандия |
3074.45 |
614.89 |
3689.34 |
4% |
10 |
3084.45 |
616.89 |
3701.34 |
16% |
25 |
3109.45 |
621.89 |
3731.34 |
|
КЦ-1728/09.09.2010 |
07.10.2010 |
07.10.2010 |
Неактивен |
2834 |
| Fexofenadine |
20080054 |
Ewofex, Film coated tablet, 120, mg, Pack: 10 |
Ewopharma International s.r.o., Словакия |
Chanelle Medical, Ireland |
3.56 |
0.71 |
4.27 |
7% |
0.25 |
3.81 |
0.76 |
4.57 |
20% |
0.71 |
4.52 |
0.9 |
5.42 |
|
HCP-9324/16.05.2016 |
02.07.2016 |
02.07.2016 |
Заличен |
1237 |
| Fexofenadine |
II-1925/ 15.04.2008 |
Ewofex, Film coated tablet, 120 mg, mg, Pack: 10 |
Ewopharma International s.r.o., Словакия |
Chanelle Medical, Ireland |
3.56 |
0.71 |
4.27 |
7% |
0.25 |
3.81 |
0.76 |
4.57 |
20% |
0.71 |
4.52 |
0.9 |
5.42 |
|
КЦРР-730/07.06.2012 |
16.07.2012 |
16.07.2012 |
Неактивен |
1237 |
| Fexofenadine |
20080055 |
Ewofex, Film coated tablet, 180, mg, Pack: 10 |
Ewopharma International s.r.o., Словакия |
Chanelle Medical, Ireland |
5.34 |
1.07 |
6.41 |
7% |
0.37 |
5.71 |
1.14 |
6.85 |
20% |
1.07 |
6.78 |
1.36 |
8.14 |
|
HCP-9325/16.05.2016 |
02.07.2016 |
02.07.2016 |
Заличен |
1238 |
| Fexofenadine |
II-1926/ 15.04.2008 |
Ewofex, Film coated tablet, 180 mg, mg, Pack: 10 |
Ewopharma International s.r.o., Словакия |
Chanelle Medical, Ireland |
5.34 |
1.07 |
6.41 |
7% |
0.37 |
5.71 |
1.14 |
6.85 |
20% |
1.07 |
6.78 |
1.36 |
8.14 |
|
КЦРР-730/07.06.2012 |
16.07.2012 |
16.07.2012 |
Неактивен |
1238 |
| Fexofenadine |
II-1926/15.04.2008 |
Ewofex, Film coated tablet, 180 mg, mg, Pack: 10 |
Ewopharma International s.r.o., Словакия |
Chanelle Medical, Ireland |
6.28 |
1.26 |
7.54 |
9% |
0.57 |
6.85 |
1.37 |
8.22 |
22% |
1.38 |
8.23 |
1.65 |
9.88 |
|
КЦ-648/05.03.2009 |
19.03.2009 |
19.03.2009 |
Неактивен |
1238 |
| Fexofenadine |
II-1925/15.04.2008 |
Ewofex, Film coated tablet, 120 mg, mg, Pack: 10 |
Ewopharma International s.r.o., Словакия |
Chanelle Medical, Ireland |
4.09 |
0.82 |
4.91 |
9% |
0.37 |
4.46 |
0.89 |
5.35 |
22% |
0.9 |
5.36 |
1.07 |
6.43 |
|
КЦ-648/05.03.2009 |
19.03.2009 |
19.03.2009 |
Неактивен |
1237 |
| Clozapine |
20130105 |
EXCLOZA, Tablet, 100, mg, Pack: 50 |
Alvogen IPCo S.àr.l, Люксембург |
Synthon BV, Microweg Нидерландия; Synthon Hispania, Испания; S. C. Labormed-Pharma SA, Румъния |
21.3 |
4.26 |
25.56 |
6% |
1.28 |
22.58 |
4.52 |
27.1 |
18% |
3.83 |
26.41 |
5.28 |
31.69 |
промяна на обстоятелства НСР-4385/07.08.2014 |
HCР-489/11.07.2013. |
29.07.2013 |
29.07.2013 |
Активен |
1914 |
| Exemestane |
ІІ -10088/ 24.06.2010 г. |
EXEMESTANE ACCORD, Film coated tablet, 25, mg, Pack: 30 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Великобритания |
27.44 |
5.49 |
32.93 |
6% |
1.65 |
29.09 |
5.82 |
34.91 |
18% |
4.94 |
34.03 |
6.81 |
40.84 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-138/06.04.2015 |
НСР-4145/23.07.2014; НСР-9837/21.07.2016 |
02.09.2016 |
02.09.2016 |
Активен |
3735 |
| Exemestane |
ІІ -10088/ 24.06.2010 г. |
EXEMESTANE ACCORD, Film coated tablet, 25, mg, Pack: 30 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Великобритания |
35.2 |
7.04 |
42.24 |
4% |
1.41 |
36.61 |
7.32 |
43.93 |
16% |
5.63 |
42.24 |
8.45 |
50.69 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-138/06.04.2015 |
НСР-4145/23.07.2014 |
02.05.2015 |
02.05.2015 |
Неактивен |
3735 |
| Exemestane |
ІІ -10088/ 24.06.2010 г. |
EXEMESTANE ACCORD, Film coated tablet, 25, mg, Pack: 30 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Великобритания |
35.52 |
7.1 |
42.62 |
4% |
1.42 |
36.94 |
7.39 |
44.33 |
16% |
5.68 |
42.62 |
8.52 |
51.14 |
|
КЦРР-2310/20.02.2013 |
11.04.2013 |
11.04.2013 |
Неактивен |
3735 |
| Exemestane |
ІІ -10088/ 24.06.2010 |
EXEMESTANE ACCORD, Film coated tablet, 25, mg, Pack: 30 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited Великобритания |
84.06 |
16.81 |
100.87 |
4% |
3.36 |
87.42 |
17.48 |
104.9 |
16% |
13.45 |
100.87 |
20.17 |
121.04 |
|
КЦРР-497/19.04.2012 |
06.06.2012 |
06.06.2012 |
Неактивен |
3735 |
| Exemestane |
№ ІІ - 10088/24.06.2010 |
EXEMESTANE ACCORD, Film coated tablet, 25, mg, Pack: 30 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited Великобритания |
101.7 |
20.34 |
122.04 |
6% |
6.1 |
107.8 |
21.56 |
129.36 |
18% |
18.31 |
126.11 |
25.22 |
151.33 |
|
КЦ-1968/26.01.2011 |
11.02.2011 |
11.02.2011 |
Неактивен |
3735 |
| Exemestane |
20100665 |
EXEMESTANE ACTAVIS, Film coated tablet, 25, mg, Pack: 30 |
Actavis Group PTC ehf., Исландия |
S.C. Sindan – Pharma SRL, Румъния |
35.2 |
7.04 |
42.24 |
4% |
1.41 |
36.61 |
7.32 |
43.93 |
16% |
5.63 |
42.24 |
8.45 |
50.69 |
цената е заличена с решение НСР-6475/18.06.2015 (в сила от 16.07.2015 ) |
НСР-2629/03.02.2014 |
18.02.2014 |
18.02.2014 |
Заличен |
2498 |
| Exemestane |
20100665/ 20.10.2010г. |
EXEMESTANE ACTAVIS, Film coated tablet, 25, mg, Pack: 30 |
Actavis Group PTC ehf., Исландия |
S.C. Sindan – Pharma SRL, Румъния |
35.52 |
7.1 |
42.62 |
4% |
1.42 |
36.94 |
7.39 |
44.33 |
16% |
5.68 |
42.62 |
8.52 |
51.14 |
|
КЦРР-2458/27.02.2013 |
14.03.2013 |
14.03.2013 |
Неактивен |
2498 |
| Exemestane |
II-10989/ 20.10.2010 |
EXEMESTANE ACTAVIS, Film coated tablet, 25, mg, Pack: 30 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan - Pharma SRL, Румъния |
84.04 |
16.81 |
100.85 |
4% |
3.36 |
87.4 |
17.48 |
104.88 |
16% |
13.45 |
100.85 |
20.17 |
121.02 |
|
КЦРР-496/19.04.2012 |
06.05.2012 |
06.05.2012 |
Неактивен |
2498 |
| Exemestane |
II-10989/ 20.10.2010 |
EXEMESTANE ACTAVIS, Film coated tablet, 25, mg, Pack: 30 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan - Pharma SRL, Румъния |
84.16 |
16.83 |
100.99 |
6% |
5.05 |
89.21 |
17.84 |
107.05 |
18% |
15.15 |
104.36 |
20.87 |
125.23 |
|
КЦ-1924/03.01.2011 |
17.01.2011 |
17.01.2011 |
Неактивен |
2498 |
| Exemestane |
20100692 |
EXEMESTANE ALVOGEN, Film coated tablet, 25, mg, Pack: 30 |
Alvogen IPCo S.àr.l, Люксембург |
EirGen Pharma Ltd. Ireland |
33.27 |
6.65 |
39.92 |
4% |
1.33 |
34.6 |
6.92 |
41.52 |
16% |
5.32 |
39.92 |
7.98 |
47.9 |
промяна в обстоятелствата НСР-6937/12.08.2015 |
НСР-3732/06.06.2014 |
23.06.2014 |
23.06.2014 |
Активен |
2922 |
| Exemestane |
20100692 |
EXEMESTANE ALVOGEN, Film coated tablet, 25, mg, Pack: 30 |
Alvogen IPCo S.àr.l, Люксембург |
EirGen Pharma Ltd. Ireland Siegfried Generics Ltd. Malta |
35.52 |
7.1 |
42.62 |
4% |
1.42 |
36.94 |
7.39 |
44.33 |
16% |
5.68 |
42.62 |
8.52 |
51.14 |
|
НСР-1215/23.09.2013 |
11.10.2013 |
11.10.2013 |
Неактивен |
2922 |
| Exemestane |
№ II - 11090 / 25.10.2010 |
EXEMESTANE ALVOGEN, Film coated tablet, 25, mg, Pack: 30 |
Alvogen IPCo S.àr.l, Люксембург |
EirGen Pharma Ltd. Ireland Siegfried Generics Ltd. Malta |
70 |
14 |
84 |
4% |
2.8 |
72.8 |
14.56 |
87.36 |
16% |
11.2 |
84 |
16.8 |
100.8 |
|
КЦ-2403/30.06.2011 |
14.07.2011 |
14.07.2011 |
Неактивен |
2922 |
| Amlodipine, Valsartan |
EU/1/06/370/019 |
Exforge, Film coated tablet, 10 mg/160 mg, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
29.2 |
5.84 |
35.04 |
6% |
1.75 |
30.95 |
6.19 |
37.14 |
18% |
5.26 |
36.21 |
7.24 |
43.45 |
|
НСР-4933/22.10.2014; НСР-9790/14.07.2016 г. |
02.08.2016 |
02.08.2016 |
Активен |
3325 |
| Amlodipine, Valsartan |
EU/1/06/370/019 |
Exforge, Film coated tablet, 10 mg/160 mg, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
29.47 |
5.89 |
35.36 |
6% |
1.77 |
31.24 |
6.25 |
37.49 |
18% |
5.3 |
36.54 |
7.31 |
43.85 |
|
НСР-4933/22.10.2014 |
06.11.2014 |
06.11.2014 |
Неактивен |
3325 |
| Amlodipine, Valsartan |
EU/1/06/370/011 |
Exforge, Film coated tablet, 5 mg/160 mg, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
27.71 |
5.54 |
33.25 |
6% |
1.66 |
29.37 |
5.87 |
35.24 |
18% |
4.99 |
34.36 |
6.87 |
41.23 |
|
НСР-7229/15.10.2015. |
30.10.2015 |
30.10.2015 |
Активен |
3450 |
| Amlodipine, Valsartan |
EU/1/06/370/011 |
Exforge, Film coated tablet, 5 mg/160 mg, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
31.98 |
6.4 |
38.38 |
4% |
1.28 |
33.26 |
6.65 |
39.91 |
16% |
5.12 |
38.38 |
7.68 |
46.06 |
|
НСР-5316/ 18.12.2014. |
01.01.2015 |
01.01.2015 |
Неактивен |
3450 |
| Amlodipine, Valsartan |
EU/1/06/370/011 |
Exforge, Film coated tablet, 5 mg/160 mg, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
33.19 |
6.64 |
39.83 |
4% |
1.33 |
34.52 |
6.9 |
41.42 |
16% |
5.31 |
39.83 |
7.97 |
47.8 |
|
НСР-3293/24.04.2014 |
08.05.2014 |
08.05.2014 |
Неактивен |
3450 |